DistantNews
Support us
Actress Park So-dam Recounts Thyroid Cancer Battle, Initial Misdiagnosis
๐Ÿ‡ฐ๐Ÿ‡ท South Korea /Health & Science

Actress Park So-dam Recounts Thyroid Cancer Battle, Initial Misdiagnosis

From Chosun Ilbo · () Korean

Translated from Korean, summarized and contextualized by DistantNews.

At a glance

News Sources not specified Context piece
  • South Korean actress Park So-dam shared her experience battling thyroid cancer.
  • She revealed that during the filming of the movie 'Ghost,' she experienced extreme fatigue, initially mistaking it for burnout.
  • Park So-dam discussed her recovery journey on the MBC show 'Playlist 109.'

South Korean actress Park So-dam has opened up about her battle with thyroid cancer, sharing poignant memories from her diagnosis and treatment. Appearing on the MBC program 'Playlist 109,' Park recounted the difficult period she faced while filming the movie 'Ghost.' She described experiencing profound fatigue and a general sense of unwellness, which she initially attributed to exhaustion and burnout.

"I thought I was just burned out," Park revealed during the broadcast, as she discussed the moment she received her cancer diagnosis. The actress, who was meeting with hosts Lee Joon, Lee Seok-hoon, and DinDin, detailed the physical and emotional toll the illness took on her. Her candid conversation offered viewers a glimpse into the personal challenges she overcame.

The interview provided insight into Park's resilience and her journey toward recovery. While the description mentions the review was written after watching the broadcast, the core of the article focuses on Park's personal testimony about her health struggles and her determination to return to her acting career.

I thought I was just burned out

โ€” Park So-damPark So-dam describing her initial feelings before being diagnosed with thyroid cancer.
DistantNews Editorial

Originally published by Chosun Ilbo in Korean. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.